Opioid Prescribing Support Implementation Guide, published by Centers for Disease Control and Prevention (CDC). This is not an authorized publication; it is the continuous build for version 1.2.3). This version is based on the current content of https://github.com/cqframework/opioid-cds/ and changes regularly. See the Directory of published versions

4.0.0 Terminology defined as part of the CDC Opioid Prescribing Guideline Implementation Guide

Note that the terminologies included in this implementation guide will need to be updated, because the ideal mechanism for distribution (as an expression) is not currently supported by the content logical definition constructs available in the FHIR ValueSet resource and all known implementations of it. Before use in a production environment, ensure you have the latest value sets based on the definitions for each value set (as defined in the inclusion/exclusion criteria for each one).

The following terminology artifacts have been defined for the CDC Opioid Prescribing Guidelines implementation guide:

4.1.0 CodeSystems

  • CDC Opioid Indicator
  • Condition Category Codes
  • Condition Clinical Status Codes
  • MedicationRequestCategory
  • MedicationRequestStatus
  • Observation Category Codes
  • US Core Condition Category Extension Codes
  • 4.2.0 ValueSets

  • Benzodiazepine Medications
  • Buprenorphine and Methadone Medications
  • CDC Malignant Cancer Conditions
  • Condition Clinical Status Active
  • Condition Category Encounter Diagnosis
  • Condition Category Problem List
  • Condition Category US Core Health Concern
  • Conditions Documenting Substance Misuse
  • Conditions Likely Terminal For Opioid Prescribing
  • Extended Release Opioids with Ambulatory Misuse Potential
  • Fentanyl-type medications
  • Fentanyl-type urine drug screening tests
  • Hospice Disposition
  • Hospice Observation Finding
  • Hospice Procedure/Request
  • Limited Life Expectancy Conditions - Enumerated
  • MedicationRequest Category Community
  • MedicationRequest Status Active
  • Naloxone Medication
  • Non-opioid Drug Urine Screenings
  • Non-synthetic opioid medications
  • Observation Category Laboratory
  • Observation Category Procedure
  • Office Visit
  • Oncology Speciality Designation
  • Opioid Analgesics with Ambulatory Abuse Potential
  • Opioid Counseling Procedure
  • Opioid Urine Screening
  • Opioid Abuse Assessment Procedure
  • Opioid Abuse Disorders
  • Pain Management Procedure
  • Pain Treatment Plans
  • PDMP Data Reviewed Findings
  • PCMP Review Procedures
  • Substance Abuse Counseling
  • Therapies Indicating End of Life Care
  • Urine Drug Screening Tests